Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications
Yingxue Gao et al.
CANCER LETTERS (2021)
Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer
Thanakorn Pungsrinont et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas
Changhwan Yoon et al.
ONCOGENESIS (2021)
PRR34-AS1 sponges miR-498 to facilitate TOMM20 and ITGA6 mediated tumor progression in HCC
Xuejing Yang et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2021)
Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression
Roosa Kaarijarvi et al.
CANCERS (2021)
Treatment-Emergent Neuroendocrine Prostate Cancer: A Clinicopathological and Immunohistochemical Analysis of 94 Cases
Qingfu Zhang et al.
FRONTIERS IN ONCOLOGY (2021)
Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020
Haibo Qiu et al.
CANCER COMMUNICATIONS (2021)
The Open University's first one-day symposium on treatment-emergent neuroendocrine prostate cancer
Rebecca L. Mather et al.
FUTURE ONCOLOGY (2020)
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer
Yota Yasumizu et al.
NATURE COMMUNICATIONS (2020)
The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling
Boris Y. Shorning et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Translocase of the outer mitochondrial membrane complex subunit 20 (TOMM20) facilitates cancer aggressiveness and therapeutic resistance in chondrosarcoma
Megan E. Roche et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Emerging role of tumor cell plasticity in modifying therapeutic response
Siyuan Qin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Mitochondrial localization, import, and mitochondrial function of the androgen receptor
Prachi Bajpai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis
Wenjuan Mei et al.
CANCERS (2019)
The Role of the Antioxidant Response in Mitochondrial Dysfunction in Degenerative Diseases: Cross-Talk between Antioxidant Defense, Autophagy, and Apoptosis
Michael L-H Huang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Cancer stem cells in prostate cancer radioresistance
Tsing Tsao et al.
CANCER LETTERS (2019)
Clinical features of neuroendocrine prostate cancer
Vincenza Conteduca et al.
EUROPEAN JOURNAL OF CANCER (2019)
Role of Androgen Receptor in Prostate Cancer: A Review
Kazutoshi Fujita et al.
WORLD JOURNAL OF MENS HEALTH (2019)
Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptor
Bahareh Eftekharzadeh et al.
NATURE COMMUNICATIONS (2019)
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Vaishali Aggarwal et al.
BIOMOLECULES (2019)
Hsp70 Binds to the Androgen Receptor N-terminal Domain and Modulates the Receptor Function in Prostate Cancer Cells
Jun Dong et al.
MOLECULAR CANCER THERAPEUTICS (2019)
TOMM20 as a potential therapeutic target of colorectal cancer
Sang-Hee Park et al.
BMB REPORTS (2019)
Molecular model for neuroendocrine prostate cancer progression
Ruiqi Chen et al.
BJU INTERNATIONAL (2018)
Clinical and molecular features of treatment-related neuroendocrine prostate cancer
Shusuke Akamatsu et al.
INTERNATIONAL JOURNAL OF UROLOGY (2018)
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
Rahul Aggarwal et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Cellular plasticity and the neuroendocrine phenotype in prostate cancer
Alastair H. Davies et al.
NATURE REVIEWS UROLOGY (2018)
Current therapeutic options in metastatic castration-resistant prostate cancer
Gianluca Ingrosso et al.
SEMINARS IN ONCOLOGY (2018)
Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson's disease
Sandra Franco-Iborra et al.
CELL DEATH & DISEASE (2018)
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
Sheng Yu Ku et al.
SCIENCE (2017)
Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells
Ruiqui Chen et al.
ONCOTARGET (2017)
Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance
Manish Kohli et al.
CLINICAL CANCER RESEARCH (2017)
Mitochondrial dysfunction and oxidative stress in aging and cancer
Anna V. Kudryavtseva et al.
ONCOTARGET (2016)
Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer
Jennifer M. Johnson et al.
SEMINARS IN ONCOLOGY (2015)
Targeting heat shock proteins in metastatic castration-resistant prostate cancer
Arun A. Azad et al.
NATURE REVIEWS UROLOGY (2015)
Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy
Manish Kohli et al.
PLOS ONE (2015)
Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer
Sebastian Christoph Schmid et al.
ADVANCES IN THERAPY (2014)
PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
Merritt P. Edlind et al.
ASIAN JOURNAL OF ANDROLOGY (2014)
Stromal-epithelial metabolic coupling in gastric cancer: Stromal MCT4 and mitochondrial TOMM20 as poor prognostic factors
Z. Zhao et al.
EJSO (2014)
Neuroendocrine Prostate Cancer (NEPC) Progressing From Conventional Prostatic Adenocarcinoma: Factors Associated With Time to Development of NEPC and Survival From NEPC Diagnosis-A Systematic Review and Pooled Analysis
Hai Tao Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer
Joseph M. Curry et al.
CELL CYCLE (2013)
Synergistic Targeting of PI3K/AKT Pathway and Androgen Receptor Axis Significantly Delays Castration-Resistant Prostate Cancer Progression In Vivo
Christian Thomas et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Karim Fizazi et al.
LANCET ONCOLOGY (2012)
Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
Yoichi Imaizumi et al.
MOLECULAR BRAIN (2012)
Androgen Receptor as a Potential Sign of Prostate Cancer Metastasis
Marie-Helene Levesque et al.
PROSTATE (2009)
Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity
Arnina Zoubeidi et al.
CANCER RESEARCH (2007)
Mitochondrial protein-import machinery: correlating structure with function
Michael J. Baker et al.
TRENDS IN CELL BIOLOGY (2007)
Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells
TC Yuan et al.
ENDOCRINE-RELATED CANCER (2006)
Estrogen receptors α and β (ERα and ERβ) and androgen receptor (AR) in human sperm:: localization of ERβ and AR in mitochondria of the midpiece
S Solakidi et al.
HUMAN REPRODUCTION (2005)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells
XQ Zhang et al.
ONCOGENE (2003)
Share Paper
